Evaluation of tumor blood flow in musculoskeletal lesions: dynamic contrast-enhanced MR imaging and its possibility when monitoring the response to preoperative chemotherapy—work in progress
Authors:
- 27 April 2007
- journal article
- research article
- Published by Springer Nature in Radiation Medicine
- Vol. 25 (3) , 94-105
Abstract
The objective of this study was to calculate tumor blood flow (TBF) in musculoskeletal lesions and to evaluate the usefulness of this parameter in differentiating malignant from benign lesions and monitoring the treatment response to preoperative chemotherapy.Keywords
This publication has 31 references indexed in Scilit:
- Measurement of Tumor Blood Flow Using Dynamic Contrast-enhanced Magnetic Resonance Imaging and Deconvolution AnalysisJournal of Computer Assisted Tomography, 2006
- Osteogenic and Ewing Sarcomas: Estimation of Necrotic Fraction during Induction Chemotherapy with Dynamic Contrast-enhanced MR ImagingRadiology, 2003
- Dynamic contrast-enhanced MR imaging in monitoring response to isolated limb perfusion in high-grade soft tissue sarcoma: initial resultsEuropean Radiology, 2003
- Assessment of osteosarcoma response to neoadjuvant chemotherapy: comparative usefulness of dynamic gadolinium-enhanced spin-echo magnetic resonance imaging and technetium-99 m skeletal angioscintigraphyEuropean Radiology, 1999
- Preoperative evaluation and monitoring chemotherapy in patients with high-grade osteogenic and Ewing's sarcoma: review of current imaging modalitiesSkeletal Radiology, 1998
- High resolution measurement of cerebral blood flow using intravascular tracer bolus passages. Part I: Mathematical approach and statistical analysisMagnetic Resonance in Medicine, 1996
- Osteosarcoma after chemotherapy: evaluation with contrast material-enhanced subtraction MR imaging.Radiology, 1992
- Osteosarcoma: MR imaging after preoperative chemotherapy.Radiology, 1990
- Musculoskeletal neoplasms: static and dynamic Gd-DTPA--enhanced MR imaging.Radiology, 1989
- PRIMARY OSTEOGENIC-SARCOMA - PATHOLOGIC ASPECTS IN 20 PATIENTS AFTER TREATMENT WITH CHEMOTHERAPY EN BLOC RESECTION, AND PROSTHETIC BONE REPLACEMENT1977